Prostate cancer is one of the leading causes of cancer deaths among men. According to the American Cancer Society, over 248,000 new cases of prostate cancer are expected to be diagnosed in the United States in 2021 alone. While traditional treatments, such as radiation and surgery, have been effective in treating prostate cancer, they can often result in unpleasant side effects, including incontinence and erectile dysfunction.
Prostate artery embolization (PAE)
However, a new prostate cancer treatment has been shown to have promising results for patients. Prostate artery embolization (PAE) is a minimally invasive procedure that involves blocking the blood supply to the prostate gland, which can help to shrink the tumor and ease symptoms.
Several studies have been conducted to determine the effectiveness of this treatment for prostate cancer, and the results have been encouraging. One study conducted by researchers at the University of Virginia and published in the journal Urology found that PAE led to a significant reduction in prostate size, improvement in urinary symptoms, and no major complications.
Another study published in the Journal of Vascular and Interventional Radiology found that PAE was a safe and effective treatment for prostate cancer patients experiencing urinary tract symptoms. The study followed 38 patients who underwent PAE and found that 63% experienced significant improvement in urinary function.
Benefits of PAE
One of the benefits of PAE is that it does not result in the same side effects as traditional treatments like surgery and radiation. Patients who undergo PAE generally experience minimal discomfort, and they can often return to their daily activities within a day or two. In addition, PAE is typically covered by insurance, making it an affordable option for many patients.
While PAE is still a relatively new treatment, it has shown great promise for prostate cancer patients. Researchers are continuing to study the treatment to determine its long-term effectiveness and any potential risks. However, for many patients, PAE offers a less invasive option for treating prostate cancer that may result in fewer side effects and a faster recovery time.
In conclusion, prostate artery embolization is a promising new treatment option for prostate cancer patients. Its minimally invasive approach offers a viable alternative to traditional treatment options and has shown to be successful in reducing prostate size, improving urinary symptoms, and preventing side effects such as incontinence and impotence. Further studies will shed more light on its long-term effectiveness, but for many patients, PAE is already considered to be an attractive option.